Dana Investment Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $497K | Buy |
35,561
+3,406
| +11% | +$47.7K | 0.02% | 454 |
|
|
2025
Q1 | $437K | Sell |
32,155
-2,147
| -6% | -$29.2K | 0.02% | 461 |
|
|
2024
Q4 | $699K | Sell |
34,302
-550
| -2% | -$11.2K | 0.02% | 426 |
|
|
2024
Q3 | $1.02M | Buy |
34,852
+583
| +2% | +$17K | 0.03% | 379 |
|
|
2024
Q2 | $796K | Buy |
34,269
+5,513
| +19% | +$128K | 0.03% | 400 |
|
|
2024
Q1 | $590K | Buy |
28,756
+4,699
| +20% | +$96.4K | 0.02% | 422 |
|
|
2023
Q4 | $516K | Sell |
24,057
-572
| -2% | -$12.3K | 0.02% | 322 |
|
|
2023
Q3 | $508K | Sell |
24,629
-2,430
| -9% | -$50.1K | 0.03% | 311 |
|
|
2023
Q2 | $799K | Buy |
27,059
+260
| +1% | +$7.67K | 0.04% | 261 |
|
|
2023
Q1 | $617K | Buy |
26,799
+1,683
| +7% | +$38.8K | 0.03% | 287 |
|
|
2022
Q4 | $698K | Buy |
25,116
+4,719
| +23% | +$131K | 0.04% | 277 |
|
|
2022
Q3 | $626K | Buy |
20,397
+7,047
| +53% | +$216K | 0.04% | 278 |
|
|
2022
Q2 | $393K | Buy |
13,350
+2,054
| +18% | +$60.5K | 0.02% | 352 |
|
|
2022
Q1 | $363K | Buy |
11,296
+1,658
| +17% | +$53.3K | 0.02% | 294 |
|
|
2021
Q4 | $430K | Buy |
9,638
+326
| +4% | +$14.5K | 0.02% | 268 |
|
|
2021
Q3 | $470K | Buy |
+9,312
| New | +$470K | 0.02% | 253 |
|